ISZO CAPITAL MANAGEMENT LP
Q1 2014 13F-HR Holdings
Net value change ($000)
—
New positions
14
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TARO PHARMACEUTICAL INDUSTRIES LTD | 122,567 | — |
| UHAL | 8,701 | — |
| NVGS | 7,171 | — |
| HRTX | 4,827 | — |
| ASSERTIO THERAPEUTICS INC COM | 4,288 | — |
| ALLIANCE HEALTHCARE SRVCS IN | 3,669 | — |
| ARQ | 3,239 | — |
| INSYS THERAPEUTICS INC | 2,778 | — |
| GLDD | 2,714 | — |
| XERIUM TECHNOLOGIES INC | 1,400 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|